La decisin sigue a la aprobacin en junio de 2024 del primer GLP-1 genrico destinado a la diabetes tipo 2
Safety Concerns When Combining Topiramate and Zepbound Published literature indicates that combining topiramate with GLP-1 agonists increases the risk of cognitive side effectsincluding memory problems, difficulty concentrating, and word-finding difficultiesbecause both drugs can affect brain function through separate mechanisms
If you have kidney disease , we need to be careful with magnesium processing
The review found that serious anesthesia risks linked to glucagon-like peptide-1 receptor agonists, or GLP-1 drugs, are uncommon for most patients and can usually be managed through individualized planning rather than stopping the medication
Some individuals utilize smart water bottles to help remind them throughout the day. What UAB clinicians are observing At UAB, clinicians are seeing more individuals incorporate GLP1 medications into their diabetes and cardiometabolic care, yet that trend has not translated into higher rates of kidney stones